Paul McEwan

Paul McEwan

Président chez seqWell, Inc.

Health Technology
Consumer Services
Commercial Services

Profil

Paul is a co–founder and currently serves as the Chief Scientific Officer of Kapa Biosystems, a company using protein evolution technology for the development of life science tools and kits.
Previously he co–founded both Agencourt Bioscience Corporation and Agencourt Personal Genomics.
Agencourt Bioscience was a market leader in the genomic services and DNA purification markets which was successfully sold to Beckman Coulter in 2005.
Agencourt Personal Genomics was acquired by Applied Biosystems and its technology was used as the basis for the SOLiDTM next–generation DNA sequencer.
Previous to these positions, Paul was a member of technology development group at the Whitehead/MIT Center for Genome Research where he developed automation and biochemical processes for the scale–up effort to sequence the Human Genome.
Paul holds a BS in Biology and Anthropology from Emory University.

Postes actifs de Paul McEwan

SociétésPosteDébut
Private Equity Investor 01/01/2006
Président -
Directeur/Membre du Conseil -
Tous les postes actifs de Paul McEwan

Anciens postes connus de Paul McEwan

SociétésPosteFin
Fondateur 01/12/2018
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Genome Research Group Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Paul McEwan

Formation de Paul McEwan

Emory University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Paul McEwan

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées8

Health Technology

Commercial Services

Health Technology

Genome Research Group

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Paul McEwan
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT